Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation

Cancer Research

Volumn 70, Issue 7, 2010, Pages 2932-2941

  Goodwin, C Rory ^a   Lal, Bachchu ^a   Zhou, Xin ^a   Ho, Sandra ^a   Xia, Shuli ^a   Taeger, Alexandra ^a   Murray, Jamie ^a   Laterra, John ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE RICH PROTEIN 61; PROTEIN KINASE B; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CYSTEINE-RICH PROTEIN 61; ENZYME ACTIVATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; MICE, NUDE; ONCOGENE PROTEIN V-AKT; PROTO-ONCOGENE PROTEINS C-MET; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77950799532     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3570     Document Type: Article

References (39)

1. Lamszus K, Laterra J, Westphal M, Rosen EM. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 1999;17:517-530
2. Lamszus K, Schmidt NO, Jin L, et al. Scatter factor promotes motilityof human glioma and neuromicrovascular endothelial cells. Int J Cancer 1998;75:19-28.
3. Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem Biophys Res Commun 1997;235:743-747 (Pubitemid 27326555)
4. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915-925
5. Walter KA, Hossain MA, Luddy C, Goel N, Reznik TE, Laterra J. Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1 -dependent transcription. Mol Cell Biol 2002;22:2703-2715
6. Abounader R, Ranganathan S, LaI B, et al. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst 1999;91:1548-1556 (Pubitemid 29457959)
7. Jin H, Yang R, Zheng Z, et al. MetMAb, the one-armed 5D5 anti-cMet antibody, inhibits orthotopic pancreatic tumor growth and improves survival. Cancer Res 2008;68:4360-4368
8. Stabile LP, Rothstein ME, Keohavong P, et al. Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis. Mol Cancer Ther 2008; 7:1913-1922
9. Du W, Hattori Y, Yamada T, et al. NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor. Blood 2007;109: 3042-3049 (Pubitemid 46482105)
10. Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005;94:29-86. (Pubitemid 41202364)
11. Bowers DC, Fan S, Walter KA, et al. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res 2000;60:4277-4283 (Pubitemid 30636617)
12. Abounader R, Reznik T, Colantuoni C, Martinez-Murillo F, Rosen EM, Laterra J. Regulation of c-Met-dependent gene expression by PTEN. Oncogene 2004;23:9173-9182 (Pubitemid 40069687)
13. Chen N, Chen CC, Lau LF. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparan sulfate proteoglycans. J Biol Chem 2000;275:24953-24961
14. Kireeva ML, Lam SC, Lau LF. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αvβ3. J Biol Chem 1998;273:3090-3096
15. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/ mouse connective tissue growth factor is mediated through integrin α(IIb)P(3). J Biol Chem 1999;274:24321-24327
16. Meyuhas R, Pikarsky E, Tavor E, et al. A key role for cyclic AMPresponsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in tumor cells. Mol Cancer Res 2008;6:1397-1409
17. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1998;95: 6355-6360
18. Wong M, Kireeva ML, Kolesnikova TV, Lau LF. Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol 1997;192: 492-508.
19. Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R. A novel CYR61 -triggered 'CYR61-αvβ3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ ERK2 MAPK signaling pathway. Oncogene 2005;24:761-779
20. Xie D, Yin D, Tong X, et al. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/ Lef signaling pathways. Cancer Res 2004;64:1987-1996 (Pubitemid 38339444)
21. Mori A, Desmond JC, Komatsu N, et al. CYR61: a new measure of lung cancer outcome. Cancer Invest 2007;25:738-741 (Pubitemid 350223176)
22. O'Kelly J, Chung A, Lemp N, et al. Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 2008;33: 59-67.
23. Sakamoto S, Yokoyama M, Zhang X, et al. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid. Endocrinology 2004;145:2929-2940
24. Sampath D, Winneker RC, Zhang Z. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17βestradiol and overexpression in human breast cancer. Endocrinology 2001;142:2540-2548
25. Tsai MS, Hornby AE, Lakins J, Lupu R. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res 2000;60:5603-5607
26. Xie D, Miller CW, O'KeIIy J, et al. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 2001;276:14187-14194
27. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001;61:8917-8923
28. Xie D, Yin D, Wang HJ, et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004;10:2072-2081
29. LaI B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potentiates glioblastoma responses to y-radiation. Clin Cancer Res 2005;11:4479-4486
30. Kim KJ, Wang L, Su YC, et al. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res 2006;12:1292-1298
31. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;24: 148-154
32. Kearns EA, Simonson LG, Schutt RW, Johnson MJ, Neil LC Characterization of monoclonal antibodies to two Treponema denticola serotypes by the indirect fluorescent-antibody assay. Microbios 1991;65:147-153
33. Reznik TE, Sang Y, Ma Y, et al. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Mol Cancer Res 2008;6:139-150
34. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354
35. Koochekpour S, Jeffers M, Rulong S, et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 1997;57:5391-5398
36. Liao HJ, de Los Santos J, Carpenter G. Contrasting role of phospholipase C-γ1 in the expression of immediate early genes induced by epidermal or platelet-derived growth factors. Exp Cell Res 2006;312: 807-816
37. Bourillot PY, Aksoy I, Schreiber V, et al. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 2009;27:1760-1771
38. Oliveira-Ferrer L, Hauschild J, Fiedler W, et al. Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway. J Exp Clin Cancer Res 2008;27:86.
39. Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C, Dedhar S. α(v) integrins regulate cell proliferation through integrinlinked kinase (ILK) in ovarian cancer cells. Oncogene 2003;22: 1688-1702